Evidence map›Paper›PMID 39583007›Full record

ArticleMolecular therapy. Oncology2024

FOS

Xiangyang Zhang, Jiayao Ma, Yihong Chen, Xiangying Deng, Yan Zhang, Ying Han, Jun Tan, Gongping Deng, Yanhong Ouyang, Yulai Zhou and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiangyang ZhangDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Jiayao MaDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Yihong ChenDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Xiangying DengDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Yan ZhangDepartment of Oncology, Yueyang People's Hospital, Yueyang Hospital Affiliated to Hunan Normal University, Yueyang 414022, Hunan, China.
Ying HanDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Jun TanDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Gongping DengDepartment of Emergency, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311 China.
Yanhong OuyangDepartment of Emergency, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311 China.
Yulai ZhouDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Changjing CaiDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Shan ZengDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Hong ShenDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While immunotherapy has marked significant advances in cancer treatment, resistance remains a challenge. The complexity of the tumor microenvironment, particularly the role of B cell subpopulations, is a critical factor affecting treatment efficacy. In this study, we conducted analyses of single-cell RNA sequencing data from immunotherapy patients (

Indexed as

anti-PD-1B cellcancerimmunotherapy resistance

Identifiers

PMID39583007
PMCPMC11584611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.